Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Lumos Diagnostics Holdings Limited ABN/ARBN Financial year ended: 66 630 476 970 30...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- FY26 Full Year Results Announcement
- FY26 Appendix 4E
- FY26 Annual Report
- Lumos to Present at 20th Bioshares Biotech Summit
- Lumos Receives FebriDx Order from PHASE Scientific
Later from Lumos Diagnostics
- Change of Director's Interest Notice - DW
- Application for quotation of securities - LDX
- Section 708A Cleansing Statement
- FebriDx Commercial Traction Continues Across US Accounts
- Change in substantial holding for LDX
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics